
CERVOMED INC. DL-,001
Share · US15713L1098 · DFFN · A3ES01 (XNCM)
6,18 EUR
13.06.2025 21:30
Current Prices from CERVOMED INC. DL-,001
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
CRVO
|
USD
|
13.06.2025 21:30
|
7,10 USD
| 7,62 USD
-6,82 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
-6,80 % | -8,33 % | -23,94 % | 10,18 % | 236,54 % | -65,30 % | -90,23 % |
Company Profile for CERVOMED INC. DL-,001 Share
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.
Company Data
Name CERVOMED INC. DL-,001
Company Diffusion Pharmaceuticals Inc.
Symbol DFFN
Website
https://www.diffusionpharma.com
Primary Exchange
Frankfurt

WKN A3ES01
ISIN US15713L1098
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Robert J. Cobuzzi Jr., Ph.D.
Country United States of America
Currency EUR
Employees 0,0 T
Address 300 East Main Street, 22902 Charlottesville
IPO Date 2008-05-23
ID Changes
Date | From | To |
---|---|---|
17.08.2023 | DFFN | CRVO |
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | DP8.F |
NASDAQ | CRVO |
NASDAQ | DFFN |
More Shares
Investors who CERVOMED INC. DL-,001 hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.